Intervention for Depression

Phase-Based Progress Estimates
Washington Hospital Center, Washington, United States
Depression+1 More
art therapy - Other
What conditions do you have?

Study Summary

This is a prospective study examining the potential impact art therapy has on postpartum depression and mother-baby bonding in women with high-risk pregnancies. Women who receive care at Washington Hospital Center's high-risk obstetrics clinic will be recruited for this study.

Eligible Conditions

  • Depression
  • High Risk Pregnancies

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 8 Secondary · Reporting Duration: one month postpartum

12-16 months
use of psychiatry medications during and after pregnancy
utilization of behavioral health/psychology/psychiatry services during pregnancy and postpartum
one month postpartum
APGAR scores
NICU admissions
birth weight
delivery complications (shoulder dystocia, low birth weight)
gestational age at time of delivery
mode of delivery
obstetrical complications (postpartum hemorrhage, OASIS, ICU admission)
reason for delivery (iatrogenic vs spontaneous)
start, middle, and end of intervention period, time of delivery, two weeks postpartum, six weeks postpartum, three months postpartum
change in maternal-infant bonding scores
changes in Edinburgh Postnatal Depression Scale scores

Trial Safety

Trial Design

2 Treatment Groups

1 of 2
1 of 2
Experimental Treatment
Non-Treatment Group

100 Total Participants · 2 Treatment Groups

Primary Treatment: Intervention · Has Placebo Group · N/A

Experimental Group · 1 Intervention: art therapy · Intervention Types: Other
PlaceboComparator Group · 1 Intervention: nothing · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: one month postpartum

Trial Background

Sara N. Iqbal, Primary Investigator
Principal Investigator
Medstar Health Research Institute
Closest Location: Washington Hospital Center · Washington, United States
Photo of washington  1Photo of washington  2Photo of washington  3
2003First Recorded Clinical Trial
1 TrialsResearching Depression
216 CompletedClinical Trials

Eligibility Criteria

Age 18+ · Female Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.